Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06549010 · ClinicalTrials.gov registry record · NA

Perimetric Testing With Virtual Reality

A NA study of Glaucoma, sponsored by Envision Health Technologies.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06549010 is a NA study of Glaucoma that is actively recruiting participants, run by Envision Health Technologies. The registered enrollment target is 60 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06549010, a NA study of Glaucoma, is actively recruiting participants, sponsored by Envision Health Technologies.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Perimetry is an essential component in the diagnosis and monitoring of glaucoma. Since the advent of Standard Automated Perimetry (SAP), one of the clinical standards has been the Humphrey Field Analyzer (HFA, Carl Zeiss AG, Oberkochen, Germany). Visual field (VF) testing provided by the HFA is standard-of-care in glaucoma clinics and other ophthalmology and optometry practices. However, the HFA is a large device that does not allow for examination outside the clinic and can be uncomfortable for patients with limited mobility. This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients. The results of this study will potentially serve as pilot data for the design of a larger study that involves the full assessment of the VR headset and its VF test, based on various testing strategies.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Perimetric test

Study Locations (1)

Illinois

  • Illinois College of Optometry / Illinois Eye Institute - Chicago

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-07-03
Est. Completion 2024-10
Phase NA

Sponsor

Envision Health Technologies

1 total trials

What the Registry Record Tells You About NCT06549010

The ClinicalTrials.gov registry entry for NCT06549010 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (93% lower). The listed sponsor is Envision Health Technologies, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Perimetric test is the first listed.

NCT06549010 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06549010 about?

NCT06549010 is a clinical study titled "Perimetric Testing With Virtual Reality". Perimetry is an essential component in the diagnosis and monitoring of glaucoma. Since the advent of Standard Automated Perimetry (SAP), one of the clinical standards has been the Humphrey Field Analyzer (HFA, Carl Zeiss AG, Oberkochen, Germany). Visual field (VF) testing provided by the HFA is stan...

What is the current status of trial NCT06549010?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-07-03. Estimated completion is 2024-10.

What conditions does trial NCT06549010 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT06549010?

The interventions under investigation include: Perimetric test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06549010?

This trial is sponsored by Envision Health Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06549010 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.